According to Transparency Market Research, the global assisted
reproductive technology market is expected to be worth US$37,789.6 mn
by the end of 2025 from US$22,100.0 mn in 2016. Between the forecast
years of 2017 and 2025, the global market is expected to rise at a
CAGR of 6.3%. The fresh non donor segment accounted for a leading
share in the global assisted reproductive technology market in 2016
and is likely to remain similarly dominant in the coming years.
Geographically, Asia Pacific is the leading contributor to the global
assisted reproductive technology market and is likely to retain a
leading share in the global market in the coming years.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=29234
By technology, the global assisted reproductive technology market is
divided into artificial insemination, in vitro fertilization,
surrogacy, and others. In vitro fertilization is by far the dominant
contributor to the global assisted reproductive technology market at
present and is likely to retain the position in the coming years due
to the growing awareness about the efficacy of in vitro fertilization
and the increasing awareness among citizens about the same. The in
vitro fertilization segment accounted for a majority share of more
than 62% in the global assisted reproductive technology market in
2016 and is likely to extend its dominance further by the end of the
2017-2025 forecast period.
Surrogacy is also likely to receive increasing demand in the coming
years, due in part to the growing demand for assisted reproductive
technology from same-sex couples. While many parents now prefer the
benefit of having their own genetic imprint in their baby through in
vitro fertilization, surrogacy is likely to receive sustained demand
in the coming years. This is borne out by the figures of the global
assisted reproductive technology market by procedure, wherein fresh
non donor contributions were the preferred choice for most
consumers.
Developing economies in Asia Pacific are likely to be vital to the
global assisted reproductive technology market in the coming years.
While the predominant social values in these regions tended to
dissuade constructive growth of the assisted reproductive technology
market, the gradual relaxation in social norms in these regions has
resulted in a promising environment for the market. The growing
prevalence of reproductive problems in Asia Pacific countries such as
India and China is thus crucial to the global assisted reproductive
technology market.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=29234
The growing investment in the healthcare sector in developing
countries is also likely to provide a major boost to the global
assisted reproductive technology market in the coming years. This
will help increase the frequency of fertility clinics in
underdeveloped regions, where sophisticated medical facilities may
still be absent.
The steady development of preimplantation genetic diagnosis (PGD) is
a key driver for the global assisted reproductive technology market.
PGD helps physicians diagnose genetic disorders likely to manifest in
the baby before it is implanted, making the technology vital for
parents looking to avoid complicated births and lifestyles. The rapid
development of the scientific database regarding genetic diseases is
further likely to remain a key boost for the global assisted
reproductive technology market.
Key players in the moderately fragmented global assisted reproductive
technology market include Merck, CooperSurgical, Inc., Irvine
Scientific, Vitrolife AB, Hamilton Thorne, Inc., Nidacon
International AB, Laboratoire CCD, Planer PLC, Esco Micro Pte. Ltd.
(Esco Group), and Nikon Corporation. Merck holds a dominant share in
the global assisted reproductive technology market due to its
widespread portfolio and steady presence in various regional
markets.
Report Overview @
https://www.transparencymarketresearch.com/assisted-reproductive-technology-market.html
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment